SIC 5122 – Drugs, Drug Proprietaries, and Druggists' Sundries
| Valuation | |
|---|---|
| Market Cap ($M) | 5.36 |
| Enterprise Value ($M) | 7.98 |
| Book Value ($M) | -1.68 |
| Book Value / Share | -0.00 |
| Price / Book | -3.20 |
| NCAV ($M) | -1.68 |
| NCAV / Share | -0.00 |
| Price / NCAV | -3.19 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.44 |
| Return on Assets (ROA) | -245.54 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.00 |
| Current Ratio | 1.00 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.25 |
| Assets | 2.26 |
| Liabilities | 3.94 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| CGRA – CGrowth Capital, Inc. | CNBI – China BCT Pharmacy Group, Inc. |
| EMGE – Emergent Health Corp | ERBB – American Green, Inc. |
| EWLU – Merion, Inc. |
Financial data and stock pages provided by
Fintel.io